Advanced search
Publication Cover
mAbs Volume 10, 2018 - Issue 2
Submit an article Journal homepage
8,669
Views
24
CrossRef citations to date
0
Altmetric
Report

Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics

Lindsay B. AveryBioMedicine Design, Pfizer Inc., Andover, MA, USAORCID Iconhttp://orcid.org/0000-0003-4920-8614
ORCID Icon,
Jason WadeBioMedicine Design, Pfizer Inc., Cambridge, MA, USA
,
Mengmeng WangBioMedicine Design, Pfizer Inc., Andover, MA, USA
,
Amy TamBioMedicine Design, Pfizer Inc., Cambridge, MA, USA
,
Amy KingBioMedicine Design, Pfizer Inc., Cambridge, MA, USA
,
Nicole Piche-NicholasBioMedicine Design, Pfizer Inc., Cambridge, MA, USAORCID Iconhttp://orcid.org/0000-0003-0695-7965
ORCID Icon,
Mania S. KavosiBioMedicine Design, Pfizer Inc., Andover, MA, USA
,
Steve PennBioMedicine Design, Pfizer Inc., Andover, MA, USA;Medicine Design, Pfizer Inc., Cambridge, MA, USA
,
David CirelliPharmaceutical Sciences, Pfizer Inc., Andover, MA, USAORCID Iconhttp://orcid.org/0000-0002-6237-1195
ORCID Icon,
Jeffrey C. KurzBioMedicine Design, Pfizer Inc., Andover, MA, USA
,
Minlei ZhangBioMedicine Design, Pfizer Inc., Andover, MA, USA
,
Orla CunninghamBiomedicine Design, Pfizer Inc., Dublin, IrelandORCID Iconhttp://orcid.org/0000-0002-3888-9541
ORCID Icon,
Rhys JonesBioMedicine Design, Pfizer Inc., Cambridge, MA, USA;Currently Medicine Design, Pfizer Inc., La Jolla, CA, USA
,
Brian J. FennellBiomedicine Design, Pfizer Inc., Dublin, Ireland
,
Barry McDonnellBiomedicine Design, Pfizer Inc., Dublin, Ireland
,
Paul SakorafasPharmaceutical Sciences, Pfizer Inc., Andover, MA, USA
,
James ApgarBioMedicine Design, Pfizer Inc., Cambridge, MA, USAORCID Iconhttp://orcid.org/0000-0002-4669-0188
ORCID Icon,
William J. FinlayBiomedicine Design, Pfizer Inc., Dublin, Ireland;Currently CodeBase, Edinburgh, UK
,
Laura LinBioMedicine Design, Pfizer Inc., Cambridge, MA, USA
,
Laird BloomBioMedicine Design, Pfizer Inc., Cambridge, MA, USACorrespondence[email protected]
&
Denise M. O'HaraBioMedicine Design, Pfizer Inc., Andover, MA, USACorrespondencedenise.o'[email protected]
 show all
Pages 244-255 | Received 12 Oct 2017, Accepted 12 Dec 2017, Published online: 29 Jan 2018

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (24)

Marissa Mock, Alex W. Jacobitz, Christopher James Langmead, Athena Sudom, Daniel Yoo, Sara C. Humphreys, Mai Alday, Larysa Alekseychyk, Nicolas Angell, Vivian Bi, Hannah Catterall, Chen-Chun Chen, Hui-Ting Chou, Kip P. Conner, Kevin D. Cook, Ana R. Correia, Andrew Dykstra, Sudipa Ghimire-Rijal, Kevin Graham, Peter Grandsard, Joon Huh, John O. Hui, Mani Jain, Victoria Jann, Lei Jia, Sheree Johnstone, Neelam Khanal, Carl Kolvenbach, Linda Narhi, Rupa Padaki, Emma M. Pelegri-O’Day, Wei Qi, Vladimir Razinkov, Austin J. Rice, Richard Smith, Christopher Spahr, Jennitte Stevens, Yax Sun, Veena A. Thomas, Sarah van Driesche, Robert Vernon, Victoria Wagner, Kenneth W. Walker, Yangjie Wei, Dwight Winters, Melissa Yang & Iain D. G. Campuzano. (2023) Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies. mAbs 15:1.
Read now
Romain Ollier, Aline Fuchs, Florence Gauye, Katarzyna Piorkowska, Sébastien Menant, Monisha Ratnam, Paolo Montanari, Florence Guilhot, Didier Phillipe, Mickael Audrain, Anne-Laure Egesipe, Damien Névoltris, Tamara Seredenina, Andrea Pfeifer, Marie Kosco-Vilbois & Tariq Afroz. (2023) Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework. mAbs 15:1.
Read now
Tushar Jain, Todd Boland & Maximiliano Vásquez. (2023) Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches. mAbs 15:1.
Read now
Catherine Y Liu, Cory L Ahonen, Michael E Brown, Ling Zhou, Martin Welin, Eric M Krauland, Robert Pejchal, Paul F Widboom & Michael B Battles. (2023) Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity. mAbs 15:1.
Read now
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Andrew Dippel, Austin Gallegos, Vineela Aleti, Arnita Barnes, Xiaoru Chen, Elizabeth Christian, Jared Delmar, Qun Du, Reza Esfandiary, Erika Farmer, Andrew Garcia, Qing Li, Jia Lin, Weiyi Liu, LeeAnn Machiesky, Neil Mody, Arun Parupudi, Meagan Prophet, Keith Rickert, Kim Rosenthal, Song Ren, Harini Shandilya, Reena Varkey, Kevin Wons, Yuling Wu, Yueh-Ming Loo, Mark T. Esser, Nicole L. Kallewaard, Sarav Rajan, Melissa Damschroder, Weichen Xu & Gilad Kaplan. (2023) Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies. mAbs 15:1.
Read now
Samantha Phan, Auralee Walmer, Eudean W. Shaw & Qing Chai. (2022) High-throughput profiling of antibody self-association in multiple formulation conditions by PEG stabilized self-interaction nanoparticle spectroscopy. mAbs 14:1.
Read now
Shihao Hu, Amita Datta-Mannan & David Z. D’Argenio. (2022) Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties. mAbs 14:1.
Read now
Rahul Khetan, Robin Curtis, Charlotte M. Deane, Johannes Thorling Hadsund, Uddipan Kar, Konrad Krawczyk, Daisuke Kuroda, Sarah A. Robinson, Pietro Sormanni, Kouhei Tsumoto, Jim Warwicker & Andrew C.R. Martin. (2022) Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics. mAbs 14:1.
Read now
Nimish Gera. (2022) The evolution of bispecific antibodies. Expert Opinion on Biological Therapy 22:8, pages 945-949.
Read now
Orla Cunningham, Martin Scott, Zhaohui Sunny Zhou & William J.J. Finlay. (2021) Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns. mAbs 13:1.
Read now
Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood & Yves Fomekong Nanfack. (2021) Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies. mAbs 13:1.
Read now
Emily K. Makowski, Lina Wu, Priyanka Gupta & Peter M. Tessier. (2021) Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. mAbs 13:1.
Read now
Sharon M. Campbell, Joseph DeBartolo, James R. Apgar, Lydia Mosyak, Virginie McManus, Sonia Beyer, Eric M. Bennett, Matthew Lambert & Orla Cunningham. (2021) Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody. mAbs 13:1.
Read now
Adam R. Root, Gurkan Guntas, Madan Katragadda, James R. Apgar, Jatin Narula, Chew Shun Chang, Sara Hanscom, Matthew McKenna, Jason Wade, Caryl Meade, Weijun Ma, Yongjing Guo, Yan Liu, Weili Duan, Claire Hendershot, Amy C. King, Yan Zhang, Eric Sousa, Amy Tam, Susan Benard, Han Yang, Kerry Kelleher, Fang Jin, Nicole Piche-Nicholas, Sinead E. Keating, Fernando Narciandi, Rosemary Lawrence-Henderson, Maya Arai, Wayne R. Stochaj, Kristine Svenson, Lidia Mosyak, Khetemcnee Lam, Christopher Francis, Kimberly Marquette, Liliana Wroblewska, H. Lily Zhu, Alfredo Darmanin Sheehan, Edward R. LaVallie, Aaron M. D’Antona, Alison Betts, Lindsay King, Edward Rosfjord, Orla Cunningham, Laura Lin, Puja Sapra, Lioudmila Tchistiakova, Divya Mathur & Laird Bloom. (2021) Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors. mAbs 13:1.
Read now
Luke Burman, Yeeting E. Chong, Sherie Duncan, Anders Klaus, Kaitlyn Rauch, Kristina Hamel, Karine Hervé, Stephanie Pfaffen, David W. Collins, Kevin Heyries, Leslie Nangle, Carl Hansen & David J. King. (2020) Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants. mAbs 12:1.
Read now
Delphine Valente, Christine Mauriac, Thorsten Schmidt, Ingo Focken, Jochen Beninga, Brian Mackness, Huawei Qiu, Pascale Vicat, Abdullah Kandira, Katarina Radošević, Srini Rao, John Darbyshire & Mostafa Kabiri. (2020) Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models. mAbs 12:1.
Read now
Marie R.G. Kopp, Adriana-Michelle Wolf Pérez, Marta Virginia Zucca, Umberto Capasso Palmiero, Brigitte Friedrichsen, Nikolai Lorenzen & Paolo Arosio. (2020) An accelerated surface-mediated stress assay of antibody instability for developability studies. mAbs 12:1.
Read now
Marc Bailly, Carl Mieczkowski, Veronica Juan, Essam Metwally, Daniela Tomazela, Jeanne Baker, Makiko Uchida, Ester Kofman, Fahimeh Raoufi, Soha Motlagh, Yao Yu, Jihea Park, Smita Raghava, John Welsh, Michael Rauscher, Gopalan Raghunathan, Mark Hsieh, Yi-Ling Chen, Hang Thu Nguyen, Nhung Nguyen, Dan Cipriano & Laurence Fayadat-Dilman. (2020) Predicting Antibody Developability Profiles Through Early Stage Discovery Screening. mAbs 12:1.
Read now
Brian C. Mackness, Julie A. Jaworski, Ekaterina Boudanova, Anna Park, Delphine Valente, Christine Mauriac, Olivier Pasquier, Thorsten Schmidt, Mostafa Kabiri, Abdullah Kandira, Katarina Radošević & Huawei Qiu. (2019) Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life. mAbs 11:7, pages 1276-1288.
Read now
William J.J. Finlay & Alexey A. Lugovskoy. (2019) De novo discovery of antibody drugs – great promise demands scrutiny. mAbs 11:5, pages 809-811.
Read now
Jinsung Noh, Okju Kim, Yushin Jung, Haejun Han, Jung-Eun Kim, Soohyun Kim, Sanghyub Lee, Jaeseong Park, Rae Hyuck Jung, Sang Il Kim, Jaejun Park, Jerome Han, Hyunho Lee, Duck Kyun Yoo, Amos C. Lee, Euijin Kwon, Taehoon Ryu, Junho Chung & Sunghoon Kwon. (2019) High-throughput retrieval of physical DNA for NGS-identifiable clones in phage display library. mAbs 11:3, pages 532-545.
Read now
Adriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, Laila Ismail Sakhnini, Ileana Rodriguez-Leon, Jais Rose Bjelke, Annette Juhl Gajhede, Leonardo De Maria, Daniel E. Otzen, Michele Vendruscolo & Nikolai Lorenzen. (2019) In vitro and in silico assessment of the developability of a designed monoclonal antibody library. mAbs 11:2, pages 388-400.
Read now
William J.J. Finlay, James E. Coleman, Jonathan S. Edwards & Kevin S. Johnson. (2019) Anti-PD1 ‘SHR-1210ʹ aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement. mAbs 11:1, pages 26-44.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.